dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Calvi, Alberto |
dc.contributor.author | Clarke, Margareta Anna |
dc.contributor.author | Prados, Ferran |
dc.contributor.author | Chard, Declan |
dc.contributor.author | Ciccarelli, Olga |
dc.contributor.author | Alberich Jordà, Manel |
dc.contributor.author | Pareto Onghena, Deborah |
dc.contributor.author | Rodríguez Barranco, Marta |
dc.contributor.author | Tur Gomez, Carmen |
dc.contributor.author | Rovira Cañellas, Alex |
dc.contributor.author | Barkhof, Frederik |
dc.contributor.author | Sastre Garriga, Jaume |
dc.date.accessioned | 2023-04-11T07:01:59Z |
dc.date.available | 2023-04-11T07:01:59Z |
dc.date.issued | 2023-03 |
dc.identifier.citation | Calvi A, Clarke MA, Prados F, Chard D, Ciccarelli O, Alberich M, et al. Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis. Mult Scler J. 2023 Mar;29(3):352–62. |
dc.identifier.issn | 1477-0970 |
dc.identifier.uri | https://hdl.handle.net/11351/9314 |
dc.description | Chronic active lesions; Multiple sclerosis; Volumetric MRI |
dc.description.abstract | Background:
Magnetic resonance imaging (MRI) markers for chronic active lesions in MS include slowly expanding lesions (SELs) and paramagnetic rim lesions (PRLs).
Objectives:
To identify the relationship between SELs and PRLs in MS, and their association with disability.
Methods:
61 people with MS (pwMS) followed retrospectively with MRI including baseline susceptibility-weighted imaging, and longitudinal T1 and T2-weighted scans. SELs were computed using deformation field maps; PRLs were visually identified. Mixed-effects models assessed differences in Expanded Disability Status Scale (EDSS) score changes between the group defined by the presence of SELs and or PRLs.
Results:
The median follow-up time was 3.2 years. At baseline, out of 1492 lesions, 616 were classified as SELs, and 80 as PRLs. 92% of patients had ⩾ 1 SEL, 56% had ⩾ 1 PRL, while both were found in 51%. SELs compared to non-SELs were more likely to also be PRLs (7% vs. 4%, p = 0.027). PRL counts positively correlated with SEL counts (ρ= 0.28, p = 0.03). SEL + PRL + patients had greater increases in EDSS over time (beta = 0.15/year, 95% confidence interval (0.04, 0.27), p = 0.009) than SEL+PRL-patients.
Conclusion:
SELs are more numerous than PRLs in pwMS. Compared with either SELs or PRLs found in isolation, their joint occurrence was associated with greater clinical progression. |
dc.language.iso | eng |
dc.publisher | SAGE Publications |
dc.relation.ispartofseries | Multiple Sclerosis Journal;29(3) |
dc.rights | Attribution 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ |
dc.source | Scientia |
dc.subject | Esclerosi múltiple - Imatgeria per ressonància magnètica |
dc.subject.mesh | Multiple Sclerosis |
dc.subject.mesh | Magnetic Resonance Imaging |
dc.title | Relationship between paramagnetic rim lesions and slowly expanding lesions in multiple sclerosis |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1177/13524585221141964 |
dc.subject.decs | esclerosis múltiple |
dc.subject.decs | imagen por resonancia magnética |
dc.relation.publishversion | https://doi.org/10.1177/13524585221141964 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Calvi A] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK. [Clarke MA, Alberich M, Pareto D, Rovira A] Secció de Neuroradiologia, Servei de Radiologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Universitat Autònoma de Barcelona, Bellaterra, Spain. [Prados F, Chard D, Ciccarelli O] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK. Biomedical Research Centre, National Institute for Health Research (NIHR) and University College London Hospitals (UCLH), London, UK. [Rodríguez Barranco M, Sastre-Garriga J] Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Tur C] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK. Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya (CEMCAT), Barcelona, Spain. [Barkhof F] Queen Square MS Centre, Department of Neuroinflammation, Institute of Neurology, Faculty of Brain Sciences, University College London (UCL), London, UK/Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London, London, UK Biomedical Research Centre, National Institute for Health Research (NIHR) and University College London Hospitals (UCLH), London, UK/Radiology & Nuclear medicine, VU University Medical Centre, Amsterdam, The Netherlands |
dc.identifier.pmid | 36515487 |
dc.identifier.wos | 000898316900001 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |